Nov 11, 2024
PathogenDx Applauded by Frost & Sullivan for Enabling Early and Precise UTI Diagnosis with Its Microarray Detection Platform
Dec 21, 2020
PathogenDx Receives AOAC INTERNATIONAL Certification for Its EnviroX-Rv Test in Detecting Novel Coronavirus on Surfaces
Oct 19, 2020
PathogenDx Announces Partnership with Prevenio to Provide First Ever Closed-Loop System to Combat Spread of Foodborne Illnesses
Sep 10, 2020
PathogenDx Selected by U.S. Department of Agriculture-Agricultural Research Service to Collaborate on Rapid Detection of Foodborne Pathogens in Food and Environmental Samples
Aug 17, 2020
PathogenDx Awarded Second NIH Grant to Develop More Accurate and Faster COVID-19 Testing
Jul 28, 2020
PathogenDx Receives Federal Grant From the NIH As Part of the RADx Program
Jun 23, 2020
PathogenDx Announces Partnership with Bertin Instruments to Combat Spread of COVID-19
Nov 18, 2019
Testing for Pathogens in Cannabis: PathogenDx Study Finds the Next Generation of DNA-Based End-Point PCR Technologies to be More Accurate Than Petri Dish & Real-time qPCR
Sep 30, 2019
PathogenDx Announces $7.5 Million in Series B Funding
Jul 02, 2019
PathogenDx and Zef Scientific Announce a Strategic Sales and Service Distribution Partnership for Microbial Testing in Canada
Mar 04, 2019
PathogenDx Launches New Brand and Microbial Testing Products For Expanding Market
Feb 21, 2019
Growing Arizona Company PathogenDx Expands Staff and Footprint
Oct 12, 2018
PathogenDx Launches the World's First Quantitative Microarray Test for Cannabis
Jul 17, 2018
DNA-Based Pathogen Testing Company PathogenDx Raises $3.4 Million in Convertible Note Round